Pretreatment with MK-801 or the Lazaroid U-83836E does not enhance striatal graft survival

5Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A large proportion of grafted striatal neurons die, and mechanisms by which they succumb may involve excitotoxicity and oxidative stress. We investigated the effects of pretreatment of the graft tissue with the N- methyl-D-aspartate (NMDA) receptor antagonist (+)dizocilpine hydrogen maleate (MK-801) and lipid peroxidation inhibitor lazaroid U-83836E on the survival of transplanted striatal neurons. Neither compound increased the survival of grafts, suggesting that NMDA-related excitotoxicity or oxidative stress may not be primary mediators of cell death in striatal grafts.

Cite

CITATION STYLE

APA

Mundt-Petersen, U., Karlsson, J., Kaminski Schierle, G. S., & Brundin, P. (2000). Pretreatment with MK-801 or the Lazaroid U-83836E does not enhance striatal graft survival. Cell Transplantation, 9(1), 73–78. https://doi.org/10.1177/096368970000900110

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free